Green tea consumption and liver disease: a systematic review
- 8 July 2008
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 28 (7), 990-996
- https://doi.org/10.1111/j.1478-3231.2008.01776.x
Abstract
To present the effect of green tea consumption against liver disease. Interventional and observational studies both in Western countries and in China and published between the years 1989 and December 2007. The articles were retrieved from Medline, Embase database, Chinese biomedicine web database and Chinese scientific journal's database using proper MESH headings and assessed by two independent investigators according to established inclusion criteria. The characteristics and outcomes of the chosen articles were displayed for further analysis and the quality of each study was also evaluated according to the widely acknowledged criteria. P<0.05 was defined as statistically significant in all enrolled trials. Ten qualified studies (eight from China, one from Japan and the other from the USA) with various outcomes such as liver cancer, cirrhosis and fatty liver disease were finally chosen. Among them, study designs differed in that there were four randomized-controlled clinical trials, two cohort, one case-control and three cross-sectional studies. The heterogeneity in the study design, outcomes, cofounders and amount of tea consumption precluded further meta-analysis. Nevertheless, eight studies showed a significant protective role of green tea against various liver diseases as determined by relative risk/odds ratio or P-value and among them, four studies showed a positive correlation between green tea intake and attenuation of liver disease. Moreover, the other two studies also presented the protective tendency of green tea against liver disease. An increased consumption of green tea may reduce the risk of liver disease.Keywords
This publication has 23 references indexed in Scilit:
- Anticarcinogenic Activity of Selenium-Enriched Green Tea Extracts in VivoJournal of Agricultural and Food Chemistry, 2007
- EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHRAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Effect of Cocoa and Tea Intake on Blood PressureArchives of Internal Medicine, 2007
- The anti-fibrotic effect of green tea with a high catechin content in the galactosamine-injured rat liverBiomedical Research, 2007
- Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster modelJournal of Ethnopharmacology, 2006
- Green tea polyphenol (−)‐epigallocatechin‐3‐gallate inhibits cyclooxygenase‐2 expression in colon carcinogenesisMolecular Carcinogenesis, 2006
- The Effects of Green Tea Consumption on Incidence of Breast Cancer and Recurrence of Breast Cancer: A Systematic Review and Meta-analysisIntegrative Cancer Therapies, 2005
- Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liverBiomedical Research, 2005
- Does Tea Affect Cardiovascular Disease? A Meta-AnalysisAmerican Journal of Epidemiology, 2001
- Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysisInternational Journal of Epidemiology, 2001